Your browser doesn't support javascript.
loading
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
Pena-Couso, Laura; Ercibengoa, María; Mercadillo, Fátima; Gómez-Sánchez, David; Inglada-Pérez, Lucía; Santos, María; Lanillos, Javier; Gutiérrez-Abad, David; Hernández, Almudena; Carbonell, Pablo; Letón, Rocío; Robledo, Mercedes; Rodríguez-Antona, Cristina; Perea, José; Urioste, Miguel.
Afiliação
  • Pena-Couso L; Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Ercibengoa M; Respiratory Infection and Antimicrobial Resistance Group, Infectious Diseases Area, BioDonostia; Microbiology Department, Osakidetza Basque Health Service, Donostialdea Integrated Health Organization, San Sebastian, Spain.
  • Mercadillo F; Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gómez-Sánchez D; Hereditary Cancer Laboratory, 12 de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.
  • Inglada-Pérez L; Clinical and Translational Lung Cancer Research Unit, i+12 Research Institute and Biomedical Research Networking Center in Oncology (CIBERONC), Madrid, Spain.
  • Santos M; Biostatistics Unit, Statistics and Operational Research Department, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.
  • Lanillos J; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gutiérrez-Abad D; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Hernández A; Medical Oncology Service, University Hospital of Fuenlabrada, Fuenlabrada, Spain.
  • Carbonell P; Dermatology Service, University Hospital of Fuenlabrada, Fuenlabrada, Spain.
  • Letón R; Biochemistry and Clinical Genetics Centre, Virgen Arrixaca University Hospital, Murcia, Spain.
  • Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Perea J; Rare Diseases Networking Biomedical Research Centre (CIBERER), Madrid, Spain.
  • Urioste M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Orphanet J Rare Dis ; 17(1): 85, 2022 02 28.
Article em En | MEDLINE | ID: mdl-35227301
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Hamartoma Múltiplo / PTEN Fosfo-Hidrolase Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Humans Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Hamartoma Múltiplo / PTEN Fosfo-Hidrolase Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Humans Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha